Will cervical carcinoma in situ recur after conization?

Aug 23, 2021 Source: Cainiu Health
Dr. An Na
Introduction
The recurrence rate after conization for cervical carcinoma in situ is relatively low. Although conization is a standard, guideline-concordant treatment for cervical carcinoma in situ and typically does not result in metastasis or recurrence, regular follow-up examinations remain essential. Recommended surveillance includes transvaginal ultrasound and Pap smear testing; vaginal discharge analysis also provides valuable diagnostic information. For middle-aged or older women without future childbearing plans, simple hysterectomy is generally the preferred option.

Cervical carcinoma in situ (CIS) refers to a condition in which cancerous cells involve the full thickness of the cervical epithelium but have not penetrated the basement membrane or invaded the underlying stroma; the lesion remains confined entirely within the squamous epithelial cells. Generally, upon diagnosis of cervical CIS, physicians will recommend immediate surgical treatment if the patient meets surgical indications—this is essential to prevent recurrence or metastasis. So, does cervical CIS recur after conization? Below, we address this question.

3 (2)_副本.jpg

Does cervical carcinoma in situ recur after conization?

The risk of recurrence after conization for cervical CIS is relatively low. Although conization is a standard, guideline-concordant surgical approach and rarely leads to metastasis or recurrence, regular follow-up examinations remain essential. Recommended surveillance includes pelvic ultrasound and cervical cytology (Pap smear); vaginal discharge analysis also provides valuable diagnostic information. For middle-aged or older women without future childbearing plans, simple hysterectomy is often the preferred option. Risk factors for recurrence of cervical CIS include early onset of sexual activity, multiple sexual partners, poor menstrual hygiene, prolonged menstruation, early marriage, early childbearing, and multiparity. One month after conization, patients should undergo repeat testing for ThinPrep cytologic test (TCT) and human papillomavirus (HPV) at a local hospital. If abnormalities are detected, prompt histopathological evaluation is required, followed by appropriate management based on the findings.

Uterus.jpg

Knowledge Extension: What are the risks associated with cervical precancerous lesions?

1. Development of complications

Cervical precancerous lesions may directly cause lower abdominal and pelvic discomfort, vaginal bleeding, and foul-smelling vaginal discharge. Clinical manifestations vary depending on sites of recurrence—for example, coughing and chest pain (if involving lungs), hematuria (if involving bladder), or rectal bleeding (if involving rectum). A palpable mass in the lower abdomen or pelvis, or lower-limb edema, may also occur. Patients may present with urinary frequency, urgency, dysuria, pelvic pressure, or hematuria—symptoms frequently misdiagnosed as urinary tract infection, thereby delaying definitive diagnosis. In severe cases, vesicovaginal fistula may develop.

2. Infertility

Cervical precancerous lesions can significantly damage the uterus—the site where the fertilized ovum implants and develops. During treatment, some patients may require hysterectomy to preserve life, thereby irrevocably depriving them of their reproductive capacity and causing profound psychological distress.

The above addresses the question: “Does cervical carcinoma in situ recur after conization?” We hope this information is helpful to you.